De la Corte, H, Expósito, MC, De Paz, MR, Ureña, LE, Jaime, FJL, Canaro, M, Coll, J, Candel, FG, Hidalgo, O, Boix, SB, Lucas, J, Vázquez, RN, Mesa, A, Sanchez, VB, Román, TA. Enhancing Physical Activity in Patients Treated With Emicizumab in Hemophilia A: Results From the HEMO-ACT Cross-Sectional Study. HAEMOPHILIA. 2026; 32DOI:. PMID:. IF:3.000(Q2/4D).

Han, JH, ten Cate, V, Li-Gao, R, Robles, AP, Sulochana, HR, Andrade-Navarro, MA, Ao, LJ, Noordam, R, Martinez-Perez, A, Sabater-Lleal, M, Soria, JM, Souto, JC, Rosendaal, FR, Wild, PS, Vlieg, AV. Genome-wide identification of loci associated with plasma coagulation factor IX activity. JOURNAL OF THROMBOSIS AND HAEMOSTASIS. 2026; 24(2)DOI:10.1016/j.jtha.2025.10.005. PMID:41161418. IF:5.000(Q1/2D).

Vallès-Cardona, G, Caixàs, A, Berges, I, Perea, G, Vilalta, N, Corripio, R. Hypercoagulability in Prader-Willi Syndrome: A case-control study exploring coagulation profiles and thrombotic risk. GENETICS IN MEDICINE. 2026; 28(4)DOI:10.1016/j.gim.2026.102536. PMID:41685566. IF:6.200(Q1/1D).

Rossi-Herring, G, Belmonte, T, Rivas-Urbina, A, Benitez, S, Rotllan, N, Crespo, J, Llorente-Cortes, V, Sanchez-Quesada, JL, de Gonzalo-Calvo, D. Circulating lipoprotein-carried miRNome analysis reveals novel VLDL-enriched microRNAs that strongly correlate with the HDL-microRNA profile. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. 2023; 162DOI:10.1016/j.biopha.2023.114623. PMID:37023624. IF:6.900(Q1/1D).

Bugiardini, R, Gale, CP, Gulati, M, Anand, SS, Maas, AHEM, Townsend, N, Vaccarino, V, Badimon, L, Cenko, E, Manfrini, O, Jha, P. Announcing The Lancet Regional Health-Europe commission on inequalities and disparities in cardiovascular health. Lancet Regional Health-Europe. 2024; 41DOI:https://ddd.uab.cat/record/324021. PMID:38725796. IF:13.000(Q1/1D).

Gorog, DA, ten Berg, JM, Campo, G, Geisler, T, Gigante, B, Grove, EL, Halvorsen, S, Huber, K, Jeong, YH, Lip, GYH, Navarese, EP, Rubboli, A, Matula, JMS, Storey, RF, Valgimigli, M, Vandenbriele, C, Vilahur, G, Ahrens, I, Ferreiro, JL. Antithrombotic therapy for secondary prevention in patients with acute coronary syndromes treated with percutaneous coronary intervention: options for personalization to reduce bleeding or ischaemic risks. European Heart Journal-Acute Cardiovascular Care. 2026; 15(4)DOI:10.1093/ehjacc/zuag021. PMID:41914626. IF:4.600(Q1/2D).

Ramos-Regaladoa, L, Schoch, L, Alcovera, S, Magaldi, M, Barriusoa, I, Padróa, T, Borrella, M, Badimona, L, Zaragozad, C, Vilahura, G. Differential regulation of the HIF-1«/apoptosis axis by miR-126-5p in cardiac cells during ischemia/reperfusion injury. Clinica E Investigacion En Arteriosclerosis. 2026; 38(3)DOI:10.1016/j.arteri.2025.500842. PMID:40816967. IF:(Q/D).

Leader, JH, Vilahur, G, Ajjan, RA, Kanji, R, Gue, YX, Farag, M, Gorog, DA. Relationship between body mass index and endogenous fibrinolytic status in 600 patients with ST-elevation myocardial infarction. CARDIOVASCULAR RESEARCH. 2026; 122(6)DOI:10.1093/cvr/cvag047. PMID:41757699. IF:13.300(Q1/1D).